SUBPART G—Specific Labeling Requirements for Specific Drug Products (§201.300 to §201.326)
- 201.300—Notice to manufacturers, packers, and distributors of glandular preparations.
- 201.301—Notice to manufacturers, packers, and distributors of estrogenic hormone preparations.
- 201.302—Notice to manufacturers, packers, and distributors of drugs for internal use which contain mineral oil.
- 201.303—Labeling of drug preparations containing significant proportions of wintergreen oil.
- 201.304—Tannic acid and barium enema preparations.
- 201.305—Isoproterenol inhalation preparations (pressurized aerosols, nebulizers, powders) for human use; warnings.
- 201.306—Potassium salt preparations intended for oral ingestion by man.
- 201.307—Sodium phosphates; package size limitation, warnings, and directions for over-the-counter sale.
- 201.308—Ipecac syrup; warnings and directions for use for over-the-counter sale.
- 201.309—Acetophenetidin (phenacetin)-containing preparations; necessary warning statement.
- 201.310—Phenindione; labeling of drug preparations intended for use by man.
- 201.312—Magnesium sulfate heptahydrate; label declaration on drug products.
- 201.313—Estradiol labeling.
- 201.314—Labeling of drug preparations containing salicylates.
- 201.315—Over-the-counter drugs for minor sore throats; suggested warning.
- 201.316—Drugs with thyroid hormone activity for human use; required warning.
- 201.317—Digitalis and related cardiotonic drugs for human use in oral dosage forms; required warning.
- 201.319—Water-soluble gums, hydrophilic gums, and hydrophilic mucilloids (including, but not limited to agar, alginic acid, calcium polycarbophil, carboxymethylcellulose sodium, carrageenan, ch
- 201.320—Warning statements for drug products containing or manufactured with chlorofluorocarbons or other ozone-depleting substances.
- 201.323—Aluminum in large and small volume parenterals used in total parenteral nutrition.
- 201.325—Over-the-counter drugs for vaginal contraceptive and spermicide use containing nonoxynol 9 as the active ingredient; required warnings and labeling information.
- 201.326—Over-the-counter drug products containing internal analgesic/antipyretic active ingredients; required warnings and other labeling.